Ciphergen Gets Ready to Bring Its Ovarian Cancer IVD to US, Europe

Ciphergen Gets Ready to Bring Its Ovarian Cancer IVD to US, Europe
By Tony Fong
December 21, 2006
ProteoMonitor
For a company recently transformed from a proteomics tool outfit into a diagnostics firm, the agreements are Ciphergen?s latest efforts in its ongoing push toward financial viability.
Paid subscription is required to view article.
Comments: 0
Votes:21